shortagewatch

Home / Companies / Jamp

Company family · HQ CA

Jamp: medicine shortages

private

As of 2 Nov 2026, 151 Jamp products have a reported shortage across 1 countries, covering 74 medicines.

Products short151rank #15 of 464
Medicines74active ingredients
Countries1/16
New in 90 days18+5 vs market pace
Typical duration2.2 yearsmedian so far
Manufacturing85%demand-driven 7%

Where

Canada151

Which therapeutic classes

Cardiovascular system41Nervous system36Digestive tract and metabolism18Cancer and immune system11Anti-infectives10Sensory organs10Blood6Genito-urinary system and sex hormones5Various4Respiratory system3

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
JampJamp: Manufacturing problem 128 (85%)85%Jamp: Increased demand 11 (7%)7%Jamp: Other 12 (8%)8%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

When its current shortages began

05101520Dec: 5Jan ’25: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 12AugSep: 0Oct: 4Nov: 0NovDec: 0Jan ’26: 1Feb: 4FebMar: 20Apr: 4May: 1MayJun: 6Jul: 0Aug: 6AugSep: 12Oct: 0Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0501001502002017: 6520172018: 3220182019: 5920192020: 1920202021: 1820212022: 13420222023: 9920232024: 11820242025: 10620252026: 1342026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Jamp151

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Jamp: 151 / 74Jamp

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Amitriptyline75 Nov 2021Manufacturing problem5/16
Irbesartan and Diuretics77 Oct 2019Manufacturing problem4/16
Irbesartan67 Oct 2019Manufacturing problem6/16
Canagliflozin510 Mar 2026Increased demand2/16
Quetiapine519 Jan 2024Manufacturing problem12/16
Temozolomide526 Aug 2026Other6/16
Alprazolam412 Oct 2018Manufacturing problem6/16
Indapamide415 Sep 2016Other4/16
Losartan423 Dec 2024Manufacturing problem6/16
Simvastatin431 Oct 2025Manufacturing problem9/16
Amoxicillin and Beta-Lactamase Inhibitor323 Dec 2024Manufacturing problem7/16
Atomoxetine312 Mar 2026Manufacturing problem11/16
Omeprazole319 Jan 2024Manufacturing problem8/16
Ondansetron331 May 2026Manufacturing problem9/16
Oxcarbazepine312 Oct 2018Manufacturing problem4/16
Ranitidine37 Oct 2019Manufacturing problem1/16
Rasagiline331 Oct 2025Manufacturing problem2/16
Ropinirole322 Nov 2019Manufacturing problem8/16
Timolol, Combinations312 Mar 2026Increased demand9/16
Zolmitriptan38 Jan 2018Manufacturing problem4/16
Ambrisentan27 Aug 2025Manufacturing problem6/16
Bendamustine219 Jul 2022Manufacturing problem7/16
Calcium Folinate226 Feb 2026Manufacturing problem7/16
Cyanocobalamin215 Sep 2016Manufacturing problem3/16
Diltiazem212 Mar 2026Manufacturing problem7/16
Finasteride223 Aug 2024Manufacturing problem8/16
Imatinib27 Aug 2025Manufacturing problem6/16
Iron, Multivitamins and Minerals22 Dec 2024Manufacturing problem1/16
Montelukast212 May 2022Other13/16
Polystyrene Sulfonate216 Oct 2023Manufacturing problem3/16
Quinine21 Apr 2020Manufacturing problem1/16
Rabeprazole27 Aug 2025Manufacturing problem5/16
Ramipril27 Oct 2019Manufacturing problem10/16
Sotalol21 Dec 2019Manufacturing problem2/16
Terbinafine215 Sep 2016Manufacturing problem5/16
Tobramycin221 Sep 2016Manufacturing problem5/16
Brimonidine115 Sep 2026Increased demand4/16
Candesartan115 Sep 2016Manufacturing problem10/16
Cetirizine112 Apr 2023Other4/16
Chlortalidone124 Aug 2026Manufacturing problem2/16
Ciprofloxacin11 Nov 2019Manufacturing problem9/16
Clobetasol115 Sep 2026Manufacturing problem2/16
Diclofenac112 Mar 2026Manufacturing problem8/16
Doxazosin115 Sep 2026Manufacturing problem5/16
Edoxaban115 Sep 2026Manufacturing problem5/16
Emtricitabine, Tenofovir Disoproxil and Efavirenz112 Mar 2026Manufacturing problem4/16
Eplerenone115 Sep 2026Manufacturing problem6/16
Flecainide131 Oct 2025Increased demand5/16
Gatifloxacin123 Jan 2026Manufacturing problem1/16
Granisetron110 Jan 2023Manufacturing problem7/16
Labetalol115 Sep 2026Manufacturing problem2/16
Methotrexate11 Dec 2020Manufacturing problem6/16
Moxifloxacin17 Aug 2025Manufacturing problem1/16
Mycophenolic Acid17 Aug 2025Manufacturing problem6/16
Olopatadine17 Aug 2025Manufacturing problem2/16
Pantoprazole11 Jan 2020Manufacturing problem9/16
Paracetamol131 May 2022Manufacturing problem10/16
Paracetamol, Combinations excl. Psycholeptics127 Nov 2017Manufacturing problem5/16
Pentoxifylline130 Jun 2026Manufacturing problem5/16
Risedronic Acid11 Nov 2019Other3/16
Risperidone131 Oct 2025Manufacturing problem13/16
Rizatriptan123 Jul 2021Manufacturing problem6/16
Rocuronium Bromide112 Mar 2026Manufacturing problem5/16
Tamsulosin120 Feb 2026Manufacturing problem6/16
Telmisartan and Diuretics115 Sep 2026Manufacturing problem4/16
Timolol115 Sep 2026Increased demand7/16
Tolterodine115 Sep 2026Manufacturing problem8/16
Tranexamic Acid130 Jun 2026Manufacturing problem10/16
Travoprost115 Sep 2026Increased demand7/16
Trospium123 Dec 2024Manufacturing problem2/16
Valaciclovir11 Nov 2019Manufacturing problem10/16
Vancomycin11 Apr 2022Manufacturing problem5/16
Voriconazole130 Jun 2026Manufacturing problem6/16
Zolpidem130 Jun 2026Manufacturing problem6/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.